FDA Adverse Event Malfunction Summary report: N

DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 8609663 · Received May 14, 2019

Report

Report Number
3004753838-2019-041856
Event Type
Malfunction
Date Received
May 14, 2019
Date of Event
April 17, 2019
Report Date
May 16, 2019
Manufacturer
DEXCOM, INC.
Product Code
PQF
UDI-DI
00386270000613
PMA / PMN Number
P120005
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE PATIENT EXPERIENCED ADVERSE EVENTS ON DIFFERENT DAYS WITH THE SAME DEVICE. THE FOLLOWING REPORTS ARE BEING SUBMITTED: 190418-003481,190418-003602,190418-003622,190418-003632,190418-003644,190418-003660,190418-003673,190418-003682,190418-003701,190418-003719 ,190418-003586.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT A LOSS OF CONNECTION OCCURRED.  A REVIEW OF THE SHARE LOGS  WAS PERFORMED AND A LOSS OF CONNECTION WAS FOUND WITHIN THE INVESTIGATION WINDOW. HOWEVER, THE DEVICE OPERATED WITHIN SPECIFICATION. THE ALLEGATION WAS NOT CONFIRMED. THE PROBABLE CAUSE COULD NOT BE DETERMINED. NO INJURY OR MEDICAL INTERVENTION WAS REPORTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A LOSS OF CONNECTION OCCURRED.THE PRODUCT WAS EVALUATED. AN EXTERNAL VISUAL INSPECTION WAS PERFORMED AND PASSED. RECEIVER CHARGES AND BOOT UP: PASSED. PERFORM PARING\CALIBRATION\PERFORMANCE\RANGE TEST: PASSED. TEST ON RECEIVER FUNCTIONAL TEST STATION: PASSED ALL RELEVANT TESTING. DOWNLOAD RX LOG AND PERFORM REVIEW OF THE RX LOG AND A LOSS OF CONNECTION WAS FOUND WITHIN THE INVESTIGATION WINDOW. THE ALLEGATION WAS CONFIRMED. THE PROBABLE CAUSE COULD NOT BE DETERMINED. NO INJURY OR MEDICAL INTERVENTION WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
401513 DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR PQF DEXCOM, INC. MT22719 5252258 00386270000613

Patients

Seq Age Sex Outcome Treatment
1 80 YR